Ruxolitinib cream 1.5% was safe and effective for the treatment of children and adolescents with a 35% or greater body surface areas affected by atopic dermatitis, according to a study.Ruxolitinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback